Plateau Levels of Viremia Correlate with the Degree of CD4+-T-cell Loss in Simian Immunodeficiency Virus SIVagm-infected Pigtailed Macaques: Variable Pathogenicity of Natural SIVagm Isolates
Overview
Authors
Affiliations
Simian immunodeficiency virus from African green monkeys (SIVagm) results in asymptomatic infection in its natural host species. The virus is not inherently apathogenic, since infection of pigtailed (PT) macaques (Macaca nemestrina) with one isolate of SIVagm results in an immunodeficiency syndrome characterized by progressive CD4+-T-cell depletion and opportunistic infections. This virus was passaged once in a PT macaque and, thus, may not be entirely reflective of the virulence of the parental strain. The goal of the present study was to assess the pathogenicity of the PT-passaged isolate (SIVagm9063) and two primary SIVagm isolates in PT macaques, including the parental strain of the PT-passaged variant. Infection of macaques with any of the three isolates resulted in high levels of primary plasma viremia by 1 week after inoculation. Viremia was quickly controlled following infection with SIVagm155; these animals have maintained CD4+-T-cell subsets and remain healthy. The plateau levels among SIVagm90- and SIVagm9063-inoculated macaques varied widely from 100 to 1 million copies/ml of plasma. Three of four animals from each of these groups progressed to AIDS. Setpoint viremia and the degree of CD4+-T-cell loss at 6 months postinfection were not significantly different between macaques inoculated with SIVagm90 and SIVagm9063. However these parameters were significantly different in SIVagm155-inoculated macaques (P values of <0.01). Considering all the macaques, the degree of CD4+-T-cell loss by 6 months postinfection correlated with the plateau levels of viremia. Thus, similar to SIVsm/mac infection of macaques and human AIDS, viral load is an excellent prognostic indicator of disease course. The inherent pathogenicity of natural SIVagm isolates varies, but such natural isolates are capable of inducing AIDS in macaques without prior macaque passage.
Jasinska A, Apetrei C, Pandrea I Front Immunol. 2023; 13:1060985.
PMID: 36713371 PMC: 9878298. DOI: 10.3389/fimmu.2022.1060985.
Genetic adaptations to SIV across chimpanzee populations.
Pawar H, Ostridge H, Schmidt J, Andres A PLoS Genet. 2022; 18(8):e1010337.
PMID: 36007015 PMC: 9467346. DOI: 10.1371/journal.pgen.1010337.
Epigenetic silencing of CD4 expression in nonpathogenic SIV infection in African green monkeys.
Mudd J, Lai S, Shah S, Rahmberg A, Flynn J, Starke C JCI Insight. 2020; 5(18).
PMID: 32841214 PMC: 7526541. DOI: 10.1172/jci.insight.139043.
Lymph Node Cellular and Viral Dynamics in Natural Hosts and Impact for HIV Cure Strategies.
Huot N, Bosinger S, Paiardini M, Reeves R, Muller-Trutwin M Front Immunol. 2018; 9:780.
PMID: 29725327 PMC: 5916971. DOI: 10.3389/fimmu.2018.00780.
Ancient hybridization and strong adaptation to viruses across African vervet monkey populations.
Svardal H, Jasinska A, Apetrei C, Coppola G, Huang Y, Schmitt C Nat Genet. 2017; 49(12):1705-1713.
PMID: 29083404 PMC: 5709169. DOI: 10.1038/ng.3980.